lancet
vol
june
wwwthelancetcom
correspond
correspond
commentari
definit
suspect
sar
fever
respiratori
symptom
includ
cough
difficulti
breath
close
contact
peopl
sar
histori
travel
epidem
area
probabl
sar
suspect
case
radiograph
evid
pneumonia
respiratori
distress
syndrom
thu
diagnosi
caus
sar
requir
clinic
definit
howev
obtain
chest
radiograph
patient
suspect
sar
practic
neither
sensibl
label
patient
suspect
sar
absenc
chang
chest
radiograph
therefor
differenti
suspect
sar
probabl
sar
basi
radiograph
chang
alon
logic
furthermor
child
hong
kong
cold
fever
cough
would
diagnos
suspect
sar
definit
revis
definit
probabl
case
sar
includ
suspect
case
sar
posit
sar
coronaviru
hong
kong
infect
diagnos
sever
definit
offici
otherwis
suspect
sar
instanc
defin
sar
infect
seriou
enough
ribavirin
start
modif
practic
one
partli
avoid
overdiagnosi
mild
febril
symptom
probabl
sar
modif
howev
could
lead
underdiagnosi
otherwis
mild
sar
case
exampl
teenag
girl
identifi
symptom
sar
chest
radiograph
chang
accord
infect
definit
histori
contact
report
start
ribavirin
coronaviru
subsequ
detect
throat
gargl
stool
specimen
revers
transcriptasepcr
label
suspect
sar
absenc
contact
histori
howev
would
probabl
judg
case
probabl
sar
resid
epidem
area
definit
contact
histori
need
case
one
coronaviru
pneumonia
sar
also
seen
case
sar
without
fever
diarrhoea
pneumonia
confus
matter
chines
translat
probabl
sar
confirm
sar
chines
media
confirm
sar
realli
mean
person
confirm
probabl
sar
local
media
must
remind
sar
realli
atyp
pneumonia
rather
subset
diseas
exampl
peopl
atyp
pneumonia
sar
view
confus
propos
term
epidem
viral
pneumonia
evp
replac
suspect
probabl
sar
classif
shown
tabl
might
use
index
surveil
epidemiolog
prognost
studi
classif
intend
triag
patient
radiograph
abnorm
might
note
present
virolog
result
might
also
avail
day
present
appli
classif
ten
children
previous
report
classif
also
help
guid
healthwork
patient
manag
newli
admit
patient
persist
fever
pneumonia
isol
prefer
singl
room
eventu
classifi
one
four
form
evp
patient
evp
c
v
evp
c
v
evp
c
v
need
isol
least
day
wherea
evp
c
v
could
discharg
symptom
improv
thank
prof
f
fok
help
letter
overdiagnosi
might
lead
anxieti
fear
associ
confin
isol
especi
children
hong
kong
public
hospit
healthwork
unabl
provid
room
everi
patient
suspect
probabl
sar
patient
diagnos
sar
may
may
sar
viru
es
risk
contract
infect
group
infect
patient
overdiagnosi
also
lead
inconveni
workplac
school
case
young
girl
develop
fever
visit
taiwan
good
exampl
sar
contact
chest
radiograph
normal
howev
taiwan
govern
label
suspect
sar
case
transport
back
hong
kong
declar
free
infect
experi
memor
one
convers
underdiagnosi
sar
could
lead
case
infect
unrecognis
potenti
pathogen
spread
commun
imprecis
definit
therefor
seriou
publichealth
consequ
done
littl
allevi
confus
surround
terminolog
sar
ambigu
term
clinic
featur
mani
patient
neither
sever
respiratori
natur
sar
initi
label
atyp
pneumonia
outbreak
china
definit
also
caus
much
confus
socal
typic
atyp
pneumonia
due
mycoplasma
chlamydia
also
acronym
sar
close
similar
ard
acut
respiratori
distress
syndrom
total
differ
mean
inde
sar
typic
kill
patient
via
viru
complic
ard
defin
sar
either
suspect
probabl
sirw
doubt
benefit
lipidlow
drug
cardiovascular
morbid
mortal
howev
disput
conclus
peter
sever
colleagu
april
p
benefici
effect
atorvastatin
present
angloscandinavian
cardiac
outcom
triallipid
lower
arm
ascotlla
lar
lindholm
ola
samuelsson
report
accompani
commentari
p
addit
benefit
lipidlow
treatment
upon
antihypertens
treatment
rather
low
ascotlla
benefit
atorvastatin
signific
patient
diabet
leftventricular
hypertrophi
previou
vascular
diseas
among
women
placebo
even
nonsignificantli
better
result
atorvastatin
posit
result
atorvastatin
signific
patient
age
year
younger
without
renal
dysfunct
metabol
syndrom
disappoint
result
among
women
accord
find
antihypertens
lipidlow
treatment
prevent
heart
attack
trial
allhatllt
pravastatin
reduc
allcaus
mortal
myocardi
infarct
fatal
coronari
heart
diseas
one
explan
find
could
allhatllt
almost
particip
women
high
proport
patient
control
group
use
statin
ascot
investig
argu
number
event
among
women
particip
diabet
small
inadequ
power
studi
howev
doubt
use
lipidlow
treatment
popul
women
low
incid
cardiovascular
event
almost
patientyear
find
atorvastatin
effect
total
mortal
accord
result
previou
primari
prevent
studi
howev
effect
cardiovascular
mortal
would
expect
view
high
number
risk
factor
among
ascotlla
particip
ascotlla
stop
prematur
year
signific
reduct
mortal
could
shown
first
year
studi
decreas
trend
mortal
addit
even
nonsignific
trend
toward
disadvantag
atorvastatin
fatal
nonfat
heart
failur
peripher
arteri
diseas
develop
diabet
mellitu
renal
impair
reason
atorvastatin
show
similar
benefici
effect
simvastatin
pravastatin
might
found
low
dose
atorvastatin
use
ascotlla
higher
dose
might
shown
better
result
also
substanti
differ
biochem
structur
differ
statin
lovastatin
pravastatin
natur
statin
fungal
origin
wherea
simvastatin
semisynthet
deriv
lovastatin
atorvastatin
fluvastatin
fulli
synthet
statin
addit
cromwel
ziajka
found
longterm
use
atorvastatin
led
tachyphylaxi
decreas
respons
physiolog
activ
agent
result
increas
ldl
cholesterol
time
despit
optimum
treatment
contrast
statin
show
evid
tachyphylaxi
atorvastatin
offer
addit
benefit
antihypertens
treatment
reduct
fatal
nonfat
cardiovascular
event
women
patient
diabet
leftventricular
hypertrophi
previou
vascular
diseaseand
without
affect
mortal
dirk
devroey
receiv
travel
expens
merck
sharp
dohm
belgium
serv
consult
receiv
research
fund
novarti
belgium
bristolmy
squibb
belgium
pfizer
belgium
sponsor
research
meet
sira
common
observ
patient
sever
acut
respiratori
syndrom
sar
pronounc
lymphopenia
report
preval
glucocorticoid
profound
effect
circul
lymphocyt
may
involv
movement
intravascular
compart
glucocorticoid
also
use
therapeut
lymphoprolif
diseas
cytoleth
action
studi
lee
colleagu
use
steroid
may
account
decreas
trend
lymphocyt
count
day
treatment
booth
colleagu
use
steroid
patient
less
half
receiv
first
h
therefor
lymphopenia
report
booth
colleagu
may
associ
use
steroid
account
patient
certainli
lymphopenia
initi
present
critic
ill
accompani
activ
hypothalamicpituitaryadren
axi
result
increas
adrenocorticotrop
hormon
acth
cortisol
maintain
integr
vasculatur
modul
action
proinflammatori
antiinflammatori
cytokin
healthi
person
sever
stress
pituitari
acth
easili
caus
adren
cortex
releas
mg
per
day
cortisol
equival
dosag
methylprednisolon
use
lee
colleagu
drive
lymphocyt
peripher
circul
therefor
lymphopenia
seen
sar
patient
indic
integr
statu
hypothalamicpituitaryadren
axi
importantli
patient
without
lymphopenia
adren
insuffici
answer
question
need
address
urgent
may
bear
whether
use
glucocorticoid
treatment
sar
thompson
provid
help
review
glucocorticoid
acut
lung
injuri
